TB-500 (Thymosin Beta-4) 10mg derived from preclinical research

derived from preclinical research

Preclinical data suggest improved immune response

This blend is widely used in laboratory and preclinical research as a model system to investigate synergistic effects on tissue regeneration

and normalized plasma insulin levels via AMPK activation

tissue remodeling

TB-500 (Thymosin Beta-4) 10mg derived from preclinical researchOverview TB 500 is the synthetic, acetylated active fragment (1723) of Thymosin Beta 4, represented by the sequence Ac LKKTETQ. This research peptide is widely studied in laboratory and preclinical environments for its involvement in actin regulation, cellular migration, angiogenesis, tissue remodeling, and inflammatory pathway modulation. Due to its defined active region and smaller molecular size, TB 500 is frequently utilized in in vitro and animal